Fact Sheet: EtO Sterilization Prevents Infection
Ethylene oxide sterilizes 20 billion medical devices in the United States each year. Sterilized equipment is critical to preventing serious, even life-threatening, infections in patients at the doctor and in the hospital every day.
Related Reading
News / Government & Legislative Affairs
AdvaMed Urges Senate Leader to Prioritize R&D Tax Credit in Any Tax Package
April 17, 2024
This week, in a letter to Senate Majority Leader Chuck Schumer, AdvaMed President and CEO Scott Whitaker underscored the critical importance of passing a tax provision that allows small businesses to deduct their research and development expenses in the year the expense was incurred. AdvaMed, the world’s largest trade association representing medical technology companies, supports the provision, which until 2022, encouraged small companies and startups to continue investing in R&D, the lifeblood of these primarily pre-commercial companies.
Resource / Regulatory Affairs
Successful Market Access of SaMD & MDSW: Decoding the Confusion in MedTech Software Development
April 12, 2024
Artificial intelligence has been in the spotlight recently, but it is not a new concept to the Food and Drug Administration (FDA) or the medtech industry. AI advancements in the medtech industry are playing a major role in improving patients’ lives through innovative care, reduced healthcare costs, and improved patient outcomes.
News / Diagnostics / Government & Legislative Affairs / VALID Act
In Congressional Testimony, AdvaMed Urges Passage of Diagnostic Regulatory Reform
March 21, 2024
Today, Zach Rothstein, Executive Director of AdvaMedDx, testified before the House Energy and Commerce Committee, Subcommittee on Health during a hearing on diagnostic test regulation and FDA’s proposed laboratory developed test (LDT) rule.
Resource / Regulatory Affairs
PFAS in Medtech
March 8, 2024
Blog / Government & Legislative Affairs
“Transparency, Inclusion, and Example”: How to Lead in Congress, Business, or Anywhere, According to Former U.S. Senator Richard Burr
March 6, 2024
Former U.S. Senator Richard Burr of North Carolina joined me on the Medtech POV podcast to share his perspective on policy and leadership. Having served in the U.S. House and Senate for nearly three decades, including tenure as Ranking Member of the Senate Committee on Health, Education, Labor and Pensions (HELP), he’s an expert on health care policy. He also has a historical perspective that anyone involved in health-care policy should value.
News / Government & Legislative Affairs
In Letter, AdvaMed CEO Calls on CMS to Release Final Breakthrough Technology Coverage Rule, Calling Delay “Puzzling”
February 29, 2024
Scott Whitaker, President and CEO of AdvaMed, the Medtech Association, sent a letter to CMS Administrator Chiquita Brooks-LaSure outlining industry disappointment in the lack of a finalized rule for Transitional Coverage for Emerging Technology.
News / Ethylene Oxide / Regulatory Affairs
AdvaMed Anticipates EtO Sterilization Rule, Voices Concern About Impact on Patient Care
February 27, 2024
By Friday, March 1, the Environmental Protection Agency is expected to finalize its regulation for the ethylene oxide (EtO) sterilization of 20 billion, or half, of all medical devices in the United States each year. AdvaMed President and CEO Scott Whitaker released the following statement:
News / Government & Legislative Affairs
AdvaMed Calls on Congress to Prevent Government Shutdown
February 26, 2024
Today, AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker on the potential government shutdown and the impact it could have on patients: